{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:52:49Z","timestamp":1792608769538,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-4361-0","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T13:02:38Z","timestamp":1565701358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1909-7530","authenticated-orcid":false,"given":"Ameet","family":"Dravid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahenderkumar","family":"Medisetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raviraj","family":"Gawali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinmay","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charuta","family":"Ghanekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Kore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niranjan","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrudula","family":"Dravid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"key":"4361_CR1","volume-title":"Global Tuberculosis Report","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Global Tuberculosis Report 2017."},{"key":"4361_CR2","unstructured":"Revised National Tuberculosis Control program. National Strategic plan for Tuberculosis elimination 2017-2025. \n                    https:\/\/tbcindia.gov.in\/WriteReadData\/NSP%20Draft%2020.02.2017%201.pdf\n                    \n                  ."},{"key":"4361_CR3","unstructured":"India TB report 2018. Revised National Tuberculosis Control program. Annual Status report. \n                    https:\/\/tbcindia.gov.in\/showfile.php?lid=3314\n                    \n                  ."},{"key":"4361_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/QAI.0b013e3181f9fb39","volume":"56","author":"A Van Rie","year":"2011","unstructured":"Van Rie A, Westreich D, Sanne I. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. J Acquir Immune Defic Syndr. 2011;56:349\u201355.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4361_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.5588\/ijtld.10.0483","volume":"15","author":"SD Lawn","year":"2011","unstructured":"Lawn SD, Harries AD, Williams BG, Chaisson RE, Losina E, De Cock KM, Wood R. Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? Int J Tuberc Lung Dis. 2011;15:571\u201381.","journal-title":"Int J Tuberc Lung Dis"},{"key":"4361_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001270","volume":"9","author":"AB Suthar","year":"2012","unstructured":"Suthar AB, Lawn SD, Amo J, Getahun H, Dye C, Sculier D, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med. 2012;9:e1001270.","journal-title":"PLoS Med"},{"key":"4361_CR7","unstructured":"National AIDS control organization. Annual Report NACO 2016-17. \n                    http:\/\/naco.gov.in\/sites\/default\/files\/NACO%20ANNUAL%20REPORT%202016-17.pdf\n                    \n                  ."},{"key":"4361_CR8","volume-title":"Guidelines for intensified tuberculosis case finding and isoniazid preventive therapy for people living with HIV in resource constrained settings","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. Guidelines for intensified tuberculosis case finding and isoniazid preventive therapy for people living with HIV in resource constrained settings. 2011."},{"issue":"Suppl 1","key":"4361_CR9","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1097\/QAD.0000000000000085","volume":"28","author":"C Pretorius","year":"2014","unstructured":"Pretorius C, Menzies NA, Chindelevitch L, Cohen T, Cori A, Eaton JW, et al. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models. AIDS. 2014;28(Suppl 1):S25\u201334.","journal-title":"AIDS"},{"key":"4361_CR10","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","volume":"19","author":"SD Lawn","year":"2005","unstructured":"Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a south African cohort. AIDS. 2005;19:2109\u201316.","journal-title":"AIDS"},{"key":"4361_CR11","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","volume":"23","author":"SD Lawn","year":"2009","unstructured":"Lawn SD, Myer L, Edwards D, Bekker LG, Wood R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS. 2009;23:1717\u201325.","journal-title":"AIDS"},{"key":"4361_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","volume":"21","author":"D Moore","year":"2007","unstructured":"Moore D, Liechty C, Ekwaru P, Were W, Mwima G, Solberg P, et al. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS. 2007;21:713\u20139.","journal-title":"AIDS"},{"key":"4361_CR13","first-page":"318","volume":"14","author":"M Dembele","year":"2010","unstructured":"Dembele M, Saleri N, Carvalho AC, Saouadogo T, Hien AD, Zabsonre I, et al. Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso. Int J Tuberc Lung Dis. 2010;14:318\u201323.","journal-title":"Int J Tuberc Lung Dis"},{"key":"4361_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2174\/1874613600903010063","volume":"3","author":"JF Etard","year":"2009","unstructured":"Etard JF, Diouf A, De Beaudrap P, Akoi K, Ngom-Gueye NF, Ndiaye I, et al. Short and long-term incidence of tuberculosis and CD4-cell count dynamic on HAART in Senegal. Open AIDS J. 2009;3:63\u201370.","journal-title":"Open AIDS J"},{"issue":"4","key":"4361_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/trstmh\/trt001","volume":"107","author":"K Choun","year":"2013","unstructured":"Choun K, Thai S, Pe R, Lorent N, Lynen L, van Griensven J. Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia. Trans R Soc Trop Med Hyg. 2013;107(4):235\u201342.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4361_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010527","volume":"5","author":"SM Hermans","year":"2010","unstructured":"Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AI, Manabe YC. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa. PLoS One. 2010;5:e10527.","journal-title":"PLoS One"},{"key":"4361_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2334-10-23","volume":"10","author":"CF Houlihan","year":"2010","unstructured":"Houlihan CF, Mutevedzi PC, Lessells RJ, Cooke GS, Tanser FC, Newell ML. The tuberculosis challenge in a rural south African HIV programme. BMC Infect Dis. 2010;10:23.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"4361_CR18","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/cid\/cis203","volume":"54","author":"J del Amo","year":"2012","unstructured":"del Amo J, Moreno S, Bucher HC, Furrer H, Logan R, Sterne J, et al. Impact of antiretroviral therapy on tuberculosis incidence among HIV positive patients in high income countries. Clin Infect Dis. 2012;54(9):1364\u201372.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"4361_CR19","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/QAI.0000000000000060","volume":"65","author":"K Naidoo","year":"2014","unstructured":"Naidoo K, Karim QA, Bhushan A, Naidoo K, Yende-Zuma N, McHunu PK, et al. High rates of tuberculosis in patients accessing HAART in rural South Africa. J Acquir Immune Defic Syndr. 2014;65(4):438\u201346.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"4361_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034156","volume":"7","author":"A Gupta","year":"2012","unstructured":"Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD. Tuberculosis incidence rates during 8 years of follow up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoS One. 2012;7(3):e34156.","journal-title":"PLoS One"},{"key":"4361_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/QAI.0b013e318218a713","volume":"57","author":"S Nicholas","year":"2011","unstructured":"Nicholas S, Sabapathy K, Ferreyra C, Varaine F, Pujades-Rodriguez M. Incidence of tuberculosis in HIV-infected patients before and after starting combined antiretroviral therapy in 8 sub-Saharan African HIV programs. J Acquir Immune Defic Syndr. 2011;57:311\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"4361_CR22","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1097\/QAD.0000000000000705","volume":"29","author":"E Liu","year":"2015","unstructured":"Liu E, Makubi A, Drain P, Spiegelman D, Sando D, Li N, Chalamilla G. Tuberculosis incidence rate and risk factors among HIV \u2013 infected adults with access to antiretroviral therapy. AIDS. 2015;29(11):1391\u20139.","journal-title":"AIDS"},{"issue":"2","key":"4361_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016961","volume":"8","author":"A Ahmed","year":"2018","unstructured":"Ahmed A, Mekonnen D, Shiferaw AM, Belayneh F, Yenit MK. Incidence and determinants of tuberculosis infection among adult patients with HIV attending HIV care in north-East Ethiopia: a retrospective cohort study. BMJ Open. 2018;8(2):e016961.","journal-title":"BMJ Open"},{"key":"4361_CR24","doi-asserted-by":"publisher","first-page":"1346104","DOI":"10.1155\/2018\/1346104","volume":"2018","author":"D Gunda","year":"2018","unstructured":"Gunda D, Maganga S, Nkandala I, Kilonzo S, Mpondo B, Shao E, et al. Prevalence and risk factors of active TB among adult HIV patients receiving ART in northwestern Tanzania: a retrospective cohort study. Can J Infect Dis Med Microbiol. 2018;2018:1346104.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"6","key":"4361_CR25","first-page":"321","volume":"29","author":"C Padmapriyadarsini","year":"2016","unstructured":"Padmapriyadarsini C, Bhavani PK, Sekar L, Anandhachitra SM, Poornagangadevi N, et al. Effectiveness of symptom screening and incidence of tuberculosis among adult and children living with HIV infection in India. Natl Med J India. 2016;29(6):321\u20135.","journal-title":"Natl Med J India"},{"issue":"2","key":"4361_CR26","first-page":"69","volume":"56","author":"S Rajasekaran","year":"2009","unstructured":"Rajasekaran S, Raja K, Jeyaseelan L, Vijilat S, Priya K, Mohan K, et al. Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile. Indian J Tuberc. 2009;56(2):69\u201376.","journal-title":"Indian J Tuberc"},{"issue":"11","key":"4361_CR27","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S1473-3099(16)30259-6","volume":"16","author":"N Arinaminpathy","year":"2016","unstructured":"Arinaminpathy N, Batra D, Khaparde S, Vualnam T, Maheshwari N, Sharma L, et al. The number of privately treated tuberculosis cases in India: estimation from drug sales data. Lancet Infect Dis. 2016;16(11):1255\u201360.","journal-title":"Lancet Infect Dis"},{"key":"4361_CR28","unstructured":"World Health Organization (WHO): Guidelines and policy briefs on HIV. \n                    https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/277395\/WHO-CDS-HIV-18.51-eng.pdf?ua=1\n                    \n                  ."},{"key":"4361_CR29","unstructured":"National AIDS control organization (NACO): Policy and Guidelines. \n                    http:\/\/naco.gov.in\/sites\/default\/files\/NACO%20-%20National%20Technical%20Guidelines%20on%20ART_October%202018%20%281%29.pdf\n                    \n                  ."},{"issue":"1","key":"4361_CR30","doi-asserted-by":"publisher","first-page":"e1000391","DOI":"10.1371\/journal.pmed.1000391","volume":"8","author":"H Getahun","year":"2011","unstructured":"Getahun H, Kittikraisak W, Heilig CM, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med. 2011;8(1):e1000391. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.1000391\n                    \n                  .","journal-title":"PLoS Med"},{"key":"4361_CR31","volume-title":"Surveillance, Planning, Financing. WHO Report","author":"Global Tuberculosis Control","year":"2002","unstructured":"Global Tuberculosis Control. Surveillance, Planning, Financing. WHO Report; 2002."},{"issue":"7","key":"4361_CR32","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/cid\/ciw566","volume":"63","author":"P Nahid","year":"2016","unstructured":"Nahid P, Dorman S, Alipanah N, Barry P, Brozek J, Cattamanchi A, Chaisson L, et al. Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63(7):853\u201367.","journal-title":"Clin Infect Dis"},{"key":"4361_CR33","unstructured":"WHO\u00a0Treatment Guidelines\u00a0for Drug-Resistant Tuberculosis, 2016 Update. \n                    https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/250125\/9789241549639-eng.pdf;jsessionid=F54F64B85BBC9736E8183D419B93E01A?sequence=1\n                    \n                  ."},{"key":"4361_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5588\/ijtld.13.0585","volume":"18","author":"CT Sreeramareddy","year":"2014","unstructured":"Sreeramareddy CT, Qin ZZ, Satyanarayana S, Pai M. Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review. Int J Tuberc Lung Dis. 2014;18:255\u201366.","journal-title":"Int J Tuberc Lung Dis"},{"key":"4361_CR35","doi-asserted-by":"publisher","first-page":"536","DOI":"10.5588\/ijtld.15.0562","volume":"20","author":"A McDowell","year":"2016","unstructured":"McDowell A, Pai M. Treatment as diagnosis and diagnosis as treatment: empirical management of presumptive tuberculosis in India. Int J Tuberc Lung Dis. 2016;20:536\u201343.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"4361_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012023","volume":"5","author":"ZF Udwadia","year":"2010","unstructured":"Udwadia ZF, Pinto LM, Uplekar MW. Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades? PLoS One. 2010;5(8):e12023.","journal-title":"PLoS One"},{"key":"4361_CR37","first-page":"117","volume":"60","author":"K Styblo","year":"1985","unstructured":"Styblo K. The relationship between the risk of tuberculosis infection and the risk of developing infectious tuberculosis. Bull Int Union Tuberc Lung Dis. 1985;60:117\u20139.","journal-title":"Bull Int Union Tuberc Lung Dis"},{"issue":"12","key":"4361_CR38","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","volume":"20","author":"SD Lawn","year":"2006","unstructured":"Lawn SD, Myer L, Bekker LG, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS. 2006;20(12):1605\u201312.","journal-title":"AIDS"},{"key":"4361_CR39","first-page":"49","volume":"7","author":"NF Walker","year":"2015","unstructured":"Walker NF, Scriven J, Meintjes G, Wilkinson RJ. Immune reconstitution inflammatory syndrome in HIV infected patients. HIV AIDS (Auckl). 2015;7:49\u201364.","journal-title":"HIV AIDS (Auckl)"},{"issue":"8","key":"4361_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/thx.2011.160168","volume":"66","author":"T Oni","year":"2011","unstructured":"Oni T, Burke R, Tsekela R, Bangani N, Seldon R, Gideon H, et al. High prevalence of subclinical tuberculosis in HIV-1 infected persons without advanced immunodeficiency : implications for TB screening. Thorax. 2011;66(8):669\u201373.","journal-title":"Thorax"},{"key":"4361_CR41","doi-asserted-by":"publisher","first-page":"14543","DOI":"10.1038\/srep14543","volume":"5","author":"H Jiang","year":"2015","unstructured":"Jiang H, Yin J, Fan Y, Liu J, Zhang Z, Liu L, et al. Gender difference in advanced HIV disease and late presentation according to European consensus definitions. Sci Rep. 2015;5:14543.","journal-title":"Sci Rep"},{"issue":"1","key":"4361_CR42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QAI.0000000000001560","volume":"77","author":"P Bock","year":"2018","unstructured":"Bock P, Jennings K, Vermaak R, Cox H, Meintjes G, Fatti G, et al. Incidence of tuberculosis among HIV-positive individuals initiating antiretroviral treatment at higher CD4 counts in the HPTN 071 (PopART) trial in South Africa. J Acquir Immune Defic Syndr. 2018;77(1):93\u2013101.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4361_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-011110-130254","volume":"6","author":"S Moir","year":"2011","unstructured":"Moir S, Chun TW, Fauci AS. Pathogenic mechanisms of HIV disease. Annu Rev Pathol. 2011;6:223\u201348.","journal-title":"Annu Rev Pathol"},{"issue":"14","key":"4361_CR44","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1097\/00002030-200109280-00012","volume":"15","author":"JE Kaplan","year":"2001","unstructured":"Kaplan JE, Hanson DL, Jones JL, Dworkin MS. Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents. AIDS. 2001;15(14):1831\u20136.","journal-title":"AIDS"},{"issue":"1","key":"4361_CR45","doi-asserted-by":"publisher","first-page":"21327","DOI":"10.7448\/IAS.20.1.21327","volume":"20","author":"L Fenner","year":"2017","unstructured":"Fenner L, Atkinson A, Boulle A, Fox MP, Prozesky H, Z\u00fcrcher K. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies. J Int AIDS Soc. 2017;20(1):21327.","journal-title":"J Int AIDS Soc"},{"key":"4361_CR46","unstructured":"World Health Organization. WHO guidelines on the use of CD4, Viral load and early infant diagnosis (EID) tests for initiation and monitoring of ART. \n                    http:\/\/www.who.int\/hiv\/amds\/102_WHO_Guidelines_on_CD4_and_VL_for_ART_Doherty.pdf\n                    \n                  ."},{"key":"4361_CR47","volume-title":"National operational guidelines for viral load testing","author":"National AIDS control organization","year":"2018","unstructured":"National AIDS control organization. National operational guidelines for viral load testing. 2018."},{"key":"4361_CR48","volume-title":"Isoniazid Preventive Therapy (IPT) and TB Infection Control (IC) for people living with HIV","author":"WHO Three I\u2019s Meeting Intensified Case Finding (ICF)","year":"2008","unstructured":"WHO Three I\u2019s Meeting Intensified Case Finding (ICF). Isoniazid Preventive Therapy (IPT) and TB Infection Control (IC) for people living with HIV. Geneva: Report of a Joint World Health Organization HIV\/aids and TB Department Meeting; 2008."},{"key":"4361_CR49","unstructured":"WHO. Programmatic update: Antiretroviral Treatment as Prevention (TASP) of HIV and TB. \n                    https:\/\/www.who.int\/hiv\/pub\/mtct\/programmatic_update_tasp\/en\/\n                    \n                  ."},{"key":"4361_CR50","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0140-6736(14)60162-8","volume":"384","author":"MX Rangaka","year":"2014","unstructured":"Rangaka MX, Wilkinson RJ, Boulle A, Glynn JR, Fielding K, van Cutsem G, et al. Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial. Lancet. 2014;384:682\u201390.","journal-title":"Lancet"},{"issue":"1","key":"4361_CR51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12879-016-2109-7","volume":"17","author":"M Semu","year":"2017","unstructured":"Semu M, Fenta TG, Medhin G, Assefa D. Effectiveness of isoniazid preventive therapy in reducing incidence of active tuberculosis among people living with HIV\/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study. BMC Infect Dis. 2017;17(1):5.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"4361_CR52","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5588\/ijtld.11.0402","volume":"16","author":"T Khawcharoenporn","year":"2012","unstructured":"Khawcharoenporn T, Apisarnthanarak A, Manosuthi W, Sungkanuparph S, Mundy LM. Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV infected Thai patients. Int J Tuberc Lung Dis. 2012;16(3):336\u201341.","journal-title":"Int J Tuberc Lung Dis."},{"issue":"1","key":"4361_CR53","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12879-019-3696-x","volume":"19","author":"A Sabasaba","year":"2019","unstructured":"Sabasaba A, Mwambi H, Somi G, Ramadhani A, Mahande MJ. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study. BMC Infect Dis. 2019;19(1):62.","journal-title":"BMC Infect Dis"},{"key":"4361_CR54","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","volume":"377","author":"T Samandari","year":"2011","unstructured":"Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, Shang N, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377:1588\u201398.","journal-title":"Lancet"},{"issue":"12","key":"4361_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047400","volume":"7","author":"S Swaminathan","year":"2012","unstructured":"Swaminathan S, Menon PA, Gopalan N, Perumal V, Santhanakrishnan RK, Ramachandran R, et al. Efficacy of a six month versus a 36 month regimen for prevention of tuberculosis in HIV infected persons in India : a randomized controlled trial. PLoS One. 2012;7(12):e47400.","journal-title":"PLoS One"},{"issue":"5","key":"4361_CR56","first-page":"942","volume":"137","author":"M Ghate","year":"2013","unstructured":"Ghate M, Tripathy S, Gangakhedkar R, Thakar M, Bhattacharya J, Choudhury I, et al. Use of first line antiretroviral therapy from a free ART programme clinic in Pune, India: a preliminary report. Indian J Med Res. 2013;137(5):942\u20139.","journal-title":"Indian J Med Res"},{"key":"4361_CR57","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/01.aids.0000176211.08581.5a","volume":"19","author":"SD Lawn","year":"2005","unstructured":"Lawn SD, Bekker LG, Wood R. How effectively does HAART restore immune responses to mycobacterium tuberculosis? Implications for tuberculosis control. AIDS. 2005;19:1113\u201324.","journal-title":"AIDS"},{"key":"4361_CR58","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/QAD.0b013e32832f51cf","volume":"24","author":"AC Crampin","year":"2010","unstructured":"Crampin AC, Mwaungulu JN, Mwaungulu FD, Mwafulirwa DT, Munthali K, Floyd S, et al. Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi. AIDS. 2010;24:417\u201326.","journal-title":"AIDS"},{"key":"4361_CR59","first-page":"942","volume":"12","author":"S Charalambous","year":"2008","unstructured":"Charalambous S, Grant AD, Moloi V, Warren R, Day JH, Van Helden P, et al. Contribution of reinfection to recurrent tuberculosis in south African gold miners. Int J Tuberc Lung Dis. 2008;12:942\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"4361_CR60","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/ije\/dyp308","volume":"39","author":"K L\u00f6nnroth","year":"2010","unstructured":"L\u00f6nnroth K, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol. 2010;39(1):149\u201355.","journal-title":"Int J Epidemiol"},{"issue":"8","key":"4361_CR61","volume":"2018","author":"M Kohli","year":"2018","unstructured":"Kohli M, Schiller I, Dendukuri N, Dheda K, Denkinger CM, Schumacher SG, et al. Xpert\u00ae MTB\/RIF assay for extrapulmonary tuberculosis and rifampicin resistance. Cochrane Database Syst Rev. 2018;2018(8):CD012768.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"4361_CR62","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367\u2013416.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4361-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4361-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4361-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T23:11:38Z","timestamp":1597187498000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4361-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4361"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4361-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]},"assertion":[{"value":"16 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was approved by the Institutional review board (IRB) of all 3 hospitals (Poona hospital and Research Centre, Ruby Hall Clinic and Noble Hospital, Pune, India) in which the study was conducted. Administrative permissions required to access the raw data were also granted by IRB. It was a retrospective cohort study and hence patients consent to participate was not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"714"}}